CONFORMITY OF EGFR MUTATION STATUS BETWEEN BLOOD PLASMA AND TUMOR TISSUE SAMPLES IN NSCLC ADENOCARCINOMA, AT DR. H. A. ROTINSULU LUNG HOSPITAL. A PRELIMINARY STUDY

Tanuwihardja Reza Kurniawan; Roesmargono Hanny

首页> 外文期刊>Respirology : >CONFORMITY OF EGFR MUTATION STATUS BETWEEN BLOOD PLASMA AND TUMOR TISSUE SAMPLES IN NSCLC ADENOCARCINOMA, AT DR. H. A. ROTINSULU LUNG HOSPITAL. A PRELIMINARY STUDY

【24h】

CONFORMITY OF EGFR MUTATION STATUS BETWEEN BLOOD PLASMA AND TUMOR TISSUE SAMPLES IN NSCLC ADENOCARCINOMA, AT DR. H. A. ROTINSULU LUNG HOSPITAL. A PRELIMINARY STUDY

机译：NSCLC腺癌血浆和肿瘤组织样品在DR中的血浆与肿瘤组织样品之间的概况。 H.A.TORINSULU肺部医院。初步研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Respirology :》 |2017年第3期|共1页
作者
Tanuwihardja Reza Kurniawan; Roesmargono Hanny;
展开▼
作者单位

Dr HA Rotinsulu Lung Hosp Pulm Dept Bandung Indonesia;

PT Prodia Widyahusada Jakarta Indonesia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. P1.01-049 Conformity of EGFR Mutation Status Between Blood Plasma and Tumor Tissue Samples Among NSCLC Adenocarcinoma Patients, at Dr. H. A. Rotinsulu Lung Hospital. A Preliminary Study [J] . R. Tanuwihardja, H. Roesmargono Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：NSCLC腺癌患者血浆和肿瘤组织样品血浆与肿瘤组织样品之间EGFR突变状态的概述。初步研究
2. Comparative study of EGFR mutations detected in malignant pleural effusion, plasma and tumor tissue in patients with adenocarcinoma of the lung [J] . Wang Shuhang, Chen Hanxiao, Zhong Jia, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2019,第期

机译：肺癌腺癌患者恶性胸腔积液，血浆和肿瘤组织中检测到EGFR突变的比较研究
3. Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686) [J] . Karlovich Chris, Goldman Jonathan W., Sun Jong-Mu, Clinical cancer research: an official journal of the American Association for Cancer Research . 2016,第10期

机译：从Rociletinib（CO-1686）的I期研究评估NSCLC患者匹配血浆和肿瘤组织中EGFR突变状态
4. Prediction of Egfr Mutation Status in Lung Adenocarcinoma Using Multi-Source Feature Representations [C] . Jianhong Cheng, Jin Liu, Meilin Jiang, IEEE International Conference on Acoustics, Speech and Signal Processing . 2021

机译：使用多源特征表示预测肺腺癌突变状态
5. Comparison of EGFR mutation status between plasma and tumor tissue in non-small cell lung cancer using the Scorpion ARMS method and the possible prognostic significance of plasma EGFR mutation status [O] . Huanli Duan, Junliang Lu, Tao Lu, 2015

机译：用Scorpion ARMS方法比较非小细胞肺癌血浆与肿瘤组织中EGFR突变状态的比较及其血浆EGFR突变状态的可能预后意义
6. Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686) [O] . Chris Karlovich, Jonathan W. Goldman, Jong-Mu Sun, 2016

机译：从罗替尼（CO-1686）研究中，NSCLC患者匹配血浆和肿瘤组织中EGFR突变状态评估（CO-1686）

CONFORMITY OF EGFR MUTATION STATUS BETWEEN BLOOD PLASMA AND TUMOR TISSUE SAMPLES IN NSCLC ADENOCARCINOMA, AT DR. H. A. ROTINSULU LUNG HOSPITAL. A PRELIMINARY STUDY

著录项

相似文献

相关主题

期刊订阅